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Abstract
Background: Laboratory services are essential for diagnosis and management of patients, and for disease control,
and should form an integral part of primary health services capable of contributing to Universal Health Coverage.
Nevertheless, they remain among the most neglected health services in resource-poor countries, including
Mozambique. The Health Directorate of Tete Province, Mozambique, developed this study to analyse the role and
perceived impact of laboratory services in primary healthcare on access, perceived service quality and disease
control.
Methods: Qualitative research was done in three primary health facilities with and three without a laboratory in
Tete Province, purposively sampled for their available services, accessibility and size. The role of the laboratory in
primary health care was explored by reviewing documents, including records and monthly reports, interviews with
clinicians, laboratory technicians and key informants (community leaders), and through focus group discussions
with beneficiaries. Numeric data were summarized in Microsoft™ Excel. Qualitative data were analysed for content
within generated categories, interpreted within the concept of Universal Health Coverage, cross validated between
the researchers.
Results: The results showed a greater use of health services, with more frequent diagnosis and monitoring of
prevalent diseases, in facilities with a laboratory as compared with facilities without. Clinicians, patients and
community leaders in facilities with a laboratory perceived an improved possibility of diagnosing and treating
prevalent diseases, resulting in greater satisfaction with the provided services. Laboratory technicians confirmed that
patients appreciated having access to laboratory tests. Clinicians, patients and community leaders in facilities
without a laboratory protested its lack, claiming that it increased the likelihood of costly referrals, delays and even
deaths.
Conclusions: The study concluded that the laboratory plays an important role in primary level health facilities, as it
is associated with greater utilization and perceived higher quality of services. Lack of a laboratory hampers patient
management, disease control and financial risk protection. Expansion of the clinical laboratory system at primary
level health facilities should be a properly funded priority of the national health system in Mozambique and similar
countries.
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Background
Adequate laboratory services support clinicians to pro-
vide quality medical care to patients, by performing tests
to confirm diagnoses or to screen for diseases, facilitat-
ing optimization and effectiveness of treatment [1, 2].
Reliance on clinical diagnosis without laboratory con-
firmation lacks specificity and reliability, may lead to
misdiagnosis in a considerable proportion of patients,
and can even be associated with increased mortality [3].
Current international health regulations identify labora-
tory services as a core capacity of health systems, and it
is recommended that all Member States of the World
Health Organization (WHO) develop and maintain such
services [4]. As such, laboratory services should form an
integral part of primary health services capable of con-
tributing to Universal Health Coverage (UHC), a con-
cept incorporated in the recently approved Sustainable
Development Goals (SDG) [2, 5].
In 2008 the WHO Regional Office for Africa sup-
ported the regional Consensus Meeting on Clinical
Laboratory Testing Harmonization and Standardization
in Maputo, Mozambique, resulting in the Maputo Dec-
laration on laboratory systems, with the aim of address-
ing the laboratory challenges which limited the scale-up
of services [1]. Since then, the need to expand and im-
prove laboratory services has been recognised, within
the larger context of health system strengthening in
countries with limited resources. Limited laboratory cap-
acity represented a major barrier to implementation and
sustainability of health programs, including for HIV,
malaria and tuberculosis [1, 6]. In response to the Dec-
laration, some countries in Africa, such as Uganda,
Rwanda, Nigeria and Tanzania, have elaborated national
laboratory policies, defining the principal guidelines and
priorities for the expansion and improvement of their la-
boratory networks, often combining the establishment of
additional laboratories with effective and reliable systems
for sample referrals [7–9].
Nevertheless, laboratory services remain a neglected
component of the health system in Mozambique. A na-
tional laboratory policy has not been developed. The
challenges include an insufficient number of trained la-
boratory staff, deficiencies in supply chains, inadequate
infrastructures and a lack of quality management, related
to inadequate allocation of government and/or donor
funding to overcome these challenges [10]. As recently
as 2013, only 23 % of health facilities in Mozambique
had a clinical laboratory, which means that a large share
of the predominantly rural population remains without
adequate access to these essential services [10]. The lim-
ited laboratory capacity continues to hinder the effective
implementation of health programs for HIV, malaria and
tuberculosis, but also for neglected tropical diseases such
as intestinal parasitosis and schistosomiasis.
Tete Province, located in central-western Mozambique,
has approximately 2.500.000 inhabitants, with elevated
levels of multidimensional poverty, while also presenting
considerable inequalities between rural and urban areas.
The province has a relatively under-resourced health sys-
tem, with estimated deficits of around 40 % in human re-
sources for health and 50 % in health facilities compared to
national targets, higher than in most other provinces.
Country statistics estimate the provincial HIV prevalence at
7 % (national prevalence: 11,5 %), while malaria, intestinal
parasitosis and schistosomiasis are endemic in the province,
as in the country. In 2014 the province had 116 health facil-
ities, of which 36 % had a clinical laboratory [11]. Although
the majority of the population live dispersed in rural areas
(the provincial population density is just 25 per km2), about
half of these laboratories are situated in facilities in provin-
cial and district capitals, leaving more rural areas relatively
underserved [11]. In Mozambique, public primary health
care services are practically free at point of use, requiring
only small financial contributions for care with exemptions
for many vulnerable groups.
To support advocacy efforts for increased attention to
the expansion of the primary care laboratory network in
Mozambique, the Tete Provincial Health Directorate
carried out this study to analyse the role of laboratory
services in primary healthcare in relation to access, per-
ceived service quality and disease control.
Methods
Study design and setting
A qualitative study was implemented to explore the role of
the availability of laboratory services on access, perceived
service quality and disease control in six rural primary
healthcare facilities (HFs) in Tete Province (three with and
without three a clinical laboratory). The facilities were pur-
posively selected for their characteristics (availability of la-
boratory services, access from the provincial capital, size of
target population, package of health services delivered and
number of health personnel), aiming for general similarity
apart from the existence of a clinical laboratory. As the se-
lected HFs are situated in rural areas, while inequalities in
multidimensional poverty are mainly between urban and
rural areas rather than between different rural areas, health
care needs were considered similar in the various target
populations of the participating HFs. For the purpose of
this study, the target population was considered to have ac-
cess to laboratory services, when their HF included a func-
tional and staffed clinical laboratory. A qualitative research
design was chosen to explore the perspectives of services
users and providers on the consequences of the availability,
or lack thereof, of primary care laboratory services. The
study was designed and implemented within on-going ef-
forts to build local capacity in scientific research, and it pre-
sented a first experience in the use of qualitative methods
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for one of the principal investigators and both research as-
sistants. The design and implementation of the study
respected all recommended methodological procedures in
the literature.
Data collection
Data collection consisted of a structured document re-
view of routine monthly reports and record books from
the HFs and their laboratories by the principal investiga-
tor, assessing the volume of services provided and diag-
nosed diseases, from January to June 2014. In addition,
we conducted 15 semi-structured individual interviews
with laboratory technicians, clinicians and community
leaders, and six focus group discussions with patients.
Each focus group discussion had between four and six
participants and lasted approximately one and a half
hour. Volunteer participants were invited from among
the patients attending the visited health facility, exclud-
ing any acutely sick patients. All laboratory technicians
and clinicians attending outpatient consultations at the
participating HFs were invited for an interview. The
community leaders invited for interview were those
known at the HFs as representatives of the local com-
munities for matters involving the health services. The
interviews and discussions, held in Portuguese or local
language as appropriate, were facilitated by two previ-
ously trained research assistants, familiar with local
health services, but not having any hierarchical relation
with the participant health personnel. One assistant
guided the conversations, while the other took notes and
attended the recordings. All conversations were held in
or close to the health facility, in a private setting, at the
end of the work day, taking care not to interfere with
the usual attendance to patients. The semi-structured
interview and discussion guides included questions soli-
citing views about the perceived usefulness and import-
ance of the laboratory services, the utilization of its
services, perceived difficulties for its use, and suggestions
for change or improvements. In health facilities without
a laboratory, the questions also asked for opinions on
how the lack of these services affected the healthcare
provided, and how useful alternatives such as sample re-
ferral systems were perceived. All interviews and discus-
sions were recorded and subsequently transcribed in
Portuguese by the facilitators. Data were collected until
saturation was reached.
Data analysis
The numeric data from reports and record books, ex-
cluding patient identifying information, were analysed in
Microsoft™ Excel. The mean number of consultations,
diagnoses and laboratory tests per month, as well as
their rate per 1.000 target population, were calculated
for the different HFs and overall for both study groups.
These means and rates were then arranged in tables and
examined for similarities and differences between HFs
with and without a laboratory. We also estimated their
implications for current utilization of laboratory capacity
and for disease control in the target populations. The
data collected from interviews and focus group discus-
sions were manually analysed for content, generating
categories of recurring ideas and phrases expressed by
the participants. The three main categories generated
within this content consisted in the utilization of labora-
tory capacity and perceived quality of diagnosis and
treatment among health professionals; perceived quality
of care among patients and community leaders, specific-
ally, perceived effectiveness and timeliness of care; and
the financial implications of access to laboratory services
or the lack thereof. Subsequently, we examined the text
fragments gathered within each of these categories for
underlying meanings, which were interpreted within the
concept of UHC as stated in the first part of target 3.8
of the SDG: “Achieve universal health coverage, includ-
ing financial risk protection, access to quality essential
healthcare services (and access to safe, effective, quality
and affordable essential medicines and vaccines) for all”
[5]. The final interpretations were reached by cross-
validation between the understandings reached from the
different data sources, based on consensus between the
two researchers, taking the viewpoint of the research as-
sistants into account.
Results
The two study groups of three HFs each included in our
study, in six different districts and outside provincial and
district capitals, had similar characteristics in terms of
average target population and number of health
personnel, package of services, and access (Table 1). In
the six HFs, routine data collection tools, record books
and monthly reports of the months January to June 2014
were reviewed, including outpatient records, monthly re-
ports of HIV and tuberculosis services, monthly reports
of maternity services, laboratory registration books. A
total of 53 participants were interviewed or collaborated
in the focus group discussions (Table 2). From the con-
tent of the semi-structured interviews and focus group
discussions, transcription, lecture and coding, and ana-
lysis yielded the information on the perception of service
quality among health professionals and service users, in-
cluding timeliness and perceived effectiveness, and on
the financial implications of access to services for the
latter group.
Service utilization and disease control
The reviewed documents indicated a higher level of health
service utilization in the HFs with a laboratory, with nearly
twice as many consultations and childbirths attended, four
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All HFs: outpatient care, maternity,
HIV and tuberculosis treatment, pharmacy;
one with inpatient services;
All HFs:
• Haemoglobin
• manual leucocytes count in peripheral blood smear
• Rapid Plasma Reagin
• Ziehl-Nielson
• thick blood smear
• microscopy for urine and faeces parasitology
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• T-cells Cluster of Differentiation 4 (Alere Pima™,
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• Polymerase Chain Reaction of HIV DNA sample collection for referral
One HF with blood transfusion service
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• Polymerase Chain Reaction of HIV DNA sample
collection for referral















times more patients starting antiretroviral treatment (ART),
and three times as many patients starting treatment for tu-
berculosis, per 1.000 target population per month, as com-
pared to HFs without a laboratory (Table 3).
We also observed important differences in the pattern
of diagnosed diseases between the two types of HFs.
Taking the different availability of the various tests into
account, HFs with a laboratory performed more tests for
malaria (36,9 vs. 15,3 per 1.000 population per month),
and also tested more people for HIV (both with rapid
tests and Polymerase Chain Reaction DNA; 6,1 and 0,1
vs. 3,7 and 0,02 per 1.000 population per month), with a
higher positivity rate (7,9 % vs. 2,5 %), than HFs without
a laboratory. They also performed more tests to assess
immune response in patients in ART (3,3 vs. 0,1 per
1.000 population per month) and to check for anaemia
(2,9 vs. 0,1 per 1.000 target population per month). In
addition, HFs with a laboratory had the capacity to con-
firm the diagnosis of a considerable number of patients
with urinary and intestinal parasitic infections (0,6 and
0,2 per 1.000 population per month, respectively), which
was not possible in the HFs without a laboratory. Spu-
tum examinations for tuberculosis resulted in more pa-
tients identified with this disease in the HFs with a
laboratory than in those without a laboratory, which
depended on sample referral (5 vs. 1 patients per month,
Table 4).
The number of tests performed each month in the
three HFs with a laboratory was nearly three times as
high as that performed in the three HFs without a la-
boratory, not only because of the additional testing cap-
acity in the laboratory itself, but also because more rapid
tests for HIV and malaria were performed by clinical
staff during consultations. As the number of consulta-
tions per month was only about twice as high in the HFs
with a laboratory than in those without, part of this dif-
ference might be explained by improved clinical prac-
tices, with less reliance on clinical diagnosis without
laboratory confirmation. It was not clear whether the
presence of a laboratory technician also improved the
quality of testing with rapid tests by clinicians, as the
positivity rate for malaria rapid tests was rather similar
between the two groups of HFs, while the higher ob-
served positivity rate of HIV rapid tests might also be re-
lated to possible differences in HIV prevalence in the
target populations.
The utilization of the available laboratory services was
moderate, as the presence of laboratories in the three
HFs added approximately 3.000 tests per month com-
pared to the HFs without a laboratory, which corre-
sponded to approximately 50 tests performed per
working day per laboratory. As a large proportion of
these tests were rapid tests for HIV or malaria, partly
performed by clinicians, spare capacity might still exist
for the additional performance of more time-consuming
examinations, such as thick blood smears for malaria or
tuberculosis, microscopy for urine and faeces parasit-
ology, or manual leucocytes count in peripheral blood
smears.
From the perspective of disease control, the difference
between the two groups of HFs in the number of positive
malaria tests indicated that, per month, over 1.300 people
more were diagnosed with malaria with laboratory con-
firmation by the three HFs with a laboratory than by the
three HFs without a laboratory, despite their very similar
target populations and expected malaria incidence. The
study collected data which included the peak malaria sea-
son during the months of January to March, which is the
period of rains locally. Although some people attended in
the HFs without a laboratory might have been treated for
malaria based on clinical suspicion only, the data suggest
that, every month, possibly hundreds of people suffering
from malaria might have gone undiagnosed and untreated
among the target population of the HFs without a labora-
tory. Similarly, albeit affecting smaller numbers of people,
every month tens of patients might have gone untreated
for HIV or tuberculosis in the target population of the
HFs without a laboratory. The presence of such number
of people with untreated malaria, HIV or tuberculosis in
this target population, likely limited the effect of local dis-
ease control efforts during the same period (such as bed
net distribution, in-door spraying, condom distribution,
behaviour change communications).
Table 3 Service utilization in both groups of HFs










Three HFs with a
laboratory
(A, B, C)





3.594 (35,0) 87 (0,8) 41 (0,4) 4 (0,03)







HFs with a laboratory
(A, B, C)
4 17 7
HFs without a laboratory
(D, E, F)
6 14 5
Total 10 31 12
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The clinicians generally thought that the availability of a
clinical laboratory enabled them to deliver services with
improved professional quality, particularly considering
diagnosis and treatment of the most common diseases.
They felt that the laboratory results facilitated their deci-
sion making regarding optimal clinical management. In
addition, they pointed out that the availability of a la-
boratory permitted a more expedient attendance. With
laboratory services present, diagnoses could be made
more quickly and treatment started without delays, as
there was no lengthy process of referral required for
samples or patients to any other HFs for laboratory ser-
vices. The perception that they were able to deliver qual-
ity care to their patients, leading to recognition by their
target population, was a source of professional satisfac-
tion, while nobody mentioned or complained that such
increased valorisation by the population of their services
might be associated with an increased workload.
Clinician (HF A-with laboratory): “The clinical la-
boratory is very important in this health centre, because
it improves the quality of our work, it facilitates the diag-
nosis of many diseases and the decision to treat them
safely. This allows for quicker attendance and it avoids
many transfers of patients”.
Clinician (HF E-without laboratory): “We have many
limitations in the diagnosis of many diseases here, and
this determines the treatment and service we provide to
our patients. For example, we do not offer tuberculosis or
HIV treatment, because of the lack of a clinical labora-
tory. We have to transfer patients often to [another
health facility] that does have a laboratory.”
Clinicians in the HFs with a laboratory expressed satis-
faction with the available tests and called even for an in-
crease in capacity, to include more tests and services (for
example, biochemistry and transfusion capacity), to fur-
ther reduce the need for sample referral and patient trans-
fers. The laboratory technicians did, however, recognize
that some tests were underused, such as microscopy for
parasites in faeces and urine, or manual leucocytes counts
in peripheral blood smears. Furthermore, they lamented
about difficulties in the logistic arrangements for sample
referrals, and demanded improvements in supply chain
management to avoid interruption of activities due to
stock-outs. Health personnel in HFs without a laboratory
complained about the limitations experienced in diagno-
sis, treatment and monitoring of patients, and called for
the urgent installation of laboratory services in their HF.
Both groups of clinicians called for more functional blood
transfusion services, and stated that they often needed to
transfer women with complications of childbirth to other,
usually distant, HFs with more readily available blood
transfusion services. Though rare, they confirmed that
some maternal deaths had occurred as a result from the
difficulties to arrange timely transfusions.
Clinician (HF B-with laboratory): “We want to do
blood transfusions here, biochemistry, CD4, and we
should also improve the supply of reagents, because we
have many stock-outs.”
Clinician (HF D-without laboratory): “They should
allocate a clinical laboratory in this HF, because you see,
there are many activities that we do not perform due to
a lack of this service. It would make such a difference, be-
cause it would surely improve our performance in diag-
nosis, treatment and management of diseases.”
In summary, in the perspective of health professionals,
especially the clinicians, service quality benefitted consid-
erably from the availability of a clinical laboratory, permit-
ting to better diagnosis and management of patients, and
more expedient attendance, despite limitations in the
laboratory’s utilization and performance. The absence of a
laboratory presented a source of frustration for health pro-
fessionals, as they could not perform to their full know-
ledge and capacity to alleviate the suffering in their
patients.
Service users
Patients and community leaders claimed that they had
more confidence in the diagnosis and treatment of the
health facilities, when these included laboratory tests.
Such tests permitted them to obtain reliable information
regarding the nature of their illness, rather than having
to depend solely upon the explanations of the attending
clinician, however educated that clinician might be. They
believed that they were more likely to receive the correct
medication for their illness after being tested at the la-
boratory, and felt more convinced of its effectiveness
and ability to cure the illness in question. As so many
patients live far from a HF, this trusted effectivity of pre-
scribed medications was considered important, to ensure
a speedy recuperation, and avoid having to come back
after potential treatment failures.
Patient (HF C-with laboratory): “This thing of testing
our blood is really very important. […] We like to have
blood tests in the laboratory, when we come here in the
hospital. Oh yes, we are sure that they will check our
blood to know what [disease] we really have and then
give us the correct medications.”
Community Leader (HF A-with laboratory): “Before
the laboratory was here, the nurses gave us medications
only based on the explanations from the patients, the
same as traditional healers and diviners, but now we re-
ceive medications based on the result of the analysis”.
Patient (HF E-without laboratory): “A place to per-
form [laboratory] tests is very important, because when a
person is ill, he does not really know what is causing the
problem, and although the doctor may be well educated
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and might say that it is because of this or that, that’s
only talking, it is necessary to do tests to know the truth
of what is happening, to check whether the strength or
the velocity of my blood is good or not. That is why it is
important for a Health Facility to have a place to per-
form [laboratory] tests.”
Patient (HF F-without laboratory): “There is no la-
boratory here, and patients are given medication accord-
ing to explanations [of the clinicians], they are like
traditional healers! Sometimes it is different from the ill-
ness the person really has, and then he has to come back
another time; we live far from here, and then we have to
leave our farms to come back many times with the same
illness.”
In addition, patients and community leaders from HFs
without a laboratory expressed dissatisfaction with the
delays in their diagnosis and treatment related to the
need for referral of samples or travel to another HF for
basic laboratory tests. Such delays were not just consid-
ered inconvenient, but even dangerous, as the illness
might progress considerably before any correct treat-
ment might be received. Remarkably, none of the partic-
ipants, neither service providers nor service users,
referred to the use of point-of-care tests to overcome
part of the limitations associated to the lack of labora-
tory services, although these tests were available for the
diagnosis of malaria and HIV.
Patient (HF D-without laboratory): “[If there were a
laboratory here], then we would be tested here, and there
would be no delays in receiving treatment, because we
would receive our test results that same visit, and we
might be attended at the same time. Now, without a la-
boratory, a person might end up dying without knowing
his test results and without having taken medication, be-
cause the test results [of samples transferred elsewhere]
delay a lot, and that is very difficult.”
From these contributions it was clear, that the patients
in these rural areas considered that a clinical laboratory
formed an essential part of quality modern biomedical
health services, an important added value compared
with the locally available traditional medicine. Patients
clearly trusted that, with laboratory examinations, their
diagnosis and treatment would be correct and expedient,
minimizing time spent waiting or travelling for health
care, and leading to a quick recovery. Without labora-
tory examinations, however, the value attributed to the
health care received would not exceed that of traditional
medicine, and as such, offer possibly less compensation
for the long waiting and travelling times.
Financial implications of access to services for patients
Patients and community leaders from HFs without a la-
boratory reported that they were facing considerable fi-
nancial hardship related to the lack of a laboratory,
including blood transfusion services. Even clinicians re-
ferred to the fact that they encountered regularly pa-
tients who were unable to afford the costs of traveling to
a neighbouring HF when a laboratory was not available
locally. Many participants mentioned the need to have
to sell farm produce to be able to gather the necessary
funds for travel to a HF with laboratory services.
Community Leader (HF A-with laboratory): “We are
very pleased with [the installation of a local laboratory],
because before we needed to sell our agricultural pro-
duce, such as corn or beans, to be able to travel in search
of a laboratory”.
Patient (HF E-without laboratory): “There is no place
to test our blood here, so sometimes we are sent to [an-
other HF] to perform tests, and that is not good, because
sometimes we have no money for transport, and then we
have to sell corn or beans or potatoes.”
Patient (HF D-without laboratory): “We can only
have tests in [the district capital], and we’ll have to sell
chickens or goats to manage to reach the laboratory.
Otherwise, we’ll just die.”
Although the laboratory services in themselves might
be free at point of use, access was clearly carrying con-
siderable financial implications for patients required to
travel to another HF for laboratory services, due to the
required transport costs. The participants recognized
that these costs could not always be assumed by every-
body, sometimes with dire consequences. Obviously, the
poorest in these generally underprivileged communities
would be at highest risk of not being able to afford the
necessary travel costs. The availability of laboratory ser-
vices at each and all rural HFs would therefore contrib-
ute considerably to the financial risk protection required
for Universal Health Coverage.
Discussion
The study results show that, in HFs with a laboratory,
there was greater utilization of health services, with
more and improved diagnosis, treatment and follow-up
of common diseases, compared to HF without a labora-
tory, despite an otherwise very similar service package
for similarly sized rural target populations, with probably
similar health care needs. The numbers of patients af-
fected by the lack of laboratory services at their local
HFs were considerable, depending upon the type of dis-
ease. In particular, malaria would not be diagnosed with
laboratory confirmation in more than 1.000 patients per
month in the target populations of the three HFs with-
out laboratory, while also tens of patients with HIV or
tuberculosis might have had to forego diagnosis and
treatment every month in these same areas. It is unlikely
that the target populations using a HF without a labora-
tory would be so much healthier than those using a HF
with a laboratory. The expected differences in incidence
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and prevalence of diseases like malaria, HIV, tubercu-
losis, anaemia, parasitic infections, or complicated child-
birth would be small between these similar and
predominantly rural areas in the same province, al-
though some transfer of neighbouring populations with-
out access to laboratory services probably occurs. The
most likely interpretation, therefore, would be that, in
HFs without a laboratory, diseases go often undiagnosed
and remain without treatment, possibly contributing to
increased morbidity, mortality, and reduced disease con-
trol in the populations without laboratory access. These
results confirm that laboratory diagnostic capacities, as a
key component of health systems, are essential for ef-
fective surveillance of diseases, as well as for their treat-
ment [1, 3, 4, 12].
Remarkably, in HFs with a laboratory more tests were
done per 1.000 target population, even in the case of dis-
eases which do have rapid point-of-care tests (POC) in
use in Mozambique. The study findings suggest that the
use of rapid tests for malaria, HIV and anaemia in HF
without a laboratory, do not adequately replace the per-
formance of a clinical laboratory. For clinicians it might
be difficult to achieve the same testing quantity and
quality with rapid tests, due to their different time allo-
cation and priorities compared to laboratory personnel.
In the high volume and understaffed health facilities of
this study, rapid tests are often not rapid enough, and a
separate service with the exclusive duty of performing
tests might therefore yield more accurate results. Other
studies have already shown that despite clear advantages,
POC testing has important limitations, and laboratory-
based testing is likely to continue to be an important
component of future diagnostic networks [13, 14].
Another important result of this study is that patients
had more confidence in health care delivered in HFs with
a laboratory, while patients attended in HFs without a la-
boratory protested its lack of availability, claiming that it
results in inadequate care or difficult and expensive jour-
neys due to referrals, and even in deaths. The higher value
attributed to health care with laboratory tests is likely to
form an important explanation for the greater utilization
of the HFs with a laboratory observed in this study. In
addition, clinicians in HFs without a laboratory felt under-
utilized and unable to perform their tasks to the profes-
sional standards for which they were trained, which surely
would be a contributing factor to prevailing low job satis-
faction and motivation, added to other known factors,
such as low salaries, poor staff housing and inadequate
supervision support [15].
Viewed within the proposed target for Universal
Health Coverage of SDG 3 (Ensure healthy lives and
promote well-being for all at all ages), these findings
suggest that it might be difficult to achieve target 3.8 of
the SDG: “Achieve universal health coverage, including
financial risk protection, access to quality essential
healthcare services […] for all” [5], without universally
providing laboratory services at primary care level, also
in rural areas. It becomes clear that the allocation of la-
boratories cannot be seen as a luxury reserved for urban
hospital settings, but must be executed throughout the
entire national health system, including in rural primary
health care facilities.
To be able to move forward towards SDG target 3.8 in
Mozambique, an expansion of appropriate laboratory infra-
structure would be necessary, consisting of space where
health professionals can perform analytical tests, to be de-
fined and allocated on the basis of number and types of
analytical tests to be performed within the HF [16]. Func-
tional electricity and water supplies should be reliably avail-
able to allow uninterrupted modern testing services within
each HF, including those of primary care level. In addition,
the investment in appropriate instrumentation, automated
laboratory equipment, and reliable consumable’s supply
chains is crucial for sustainable laboratories [17]. To
achieve such conditions in poor-resourced countries, such
as Mozambique, would require substantial and continuous
funding of a well-designed National Laboratory Policy. This
policy would also have to consider the training and place-
ment of corresponding numbers of laboratory technicians
of appropriate technical capacities, to ensure that the clin-
ical laboratories built and equipped would be adequately
staffed, in combination with other prerequisites, including
improved supply chain management, supervision and tech-
nical support, improved quality assurance and information
systems, in order to ensure a viable decentralised laboratory
system [18, 19].
Limitations of this study include the fact that the prin-
cipal investigators originated within the public health-
care system in the province, which likely coloured the
responses of both service providers and users, although
efforts were made to avoid hierarchical relations, such as
the use of research assistants not in hierarchical relation-
ship with the participating HF staff. In addition, disease
statistics from populations in areas without laboratory
might have spilled over to HFs with a laboratory, as for
sicker patients it would be more imperative to travel and
look for services elsewhere. Their test results might thus
inflate the utilization and positivity rates in HFs with a
laboratory. A study design with ‘before and after’ analysis
might have been more useful to illustrate the impact of
laboratory services. However, due to the slow pace of la-
boratory service expansion, the many other interventions
routinely done to affect service quality and utilization,
and the frequent changes in the health information sys-
tems used in Mozambique, which hinders comparison of
data over time, such design was judged unfeasible.
As this is a qualitative study, in the specific situation of
Tete province in Mozambique, caution is warranted in the
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generalisation of these results to the entire country or Af-
rican region. Still, the study provides information which is
consistent with existing literature on the topic. The setting
of the six participating HFs is typical of many others in
rural areas with low population density in Mozambique
and in other low-income countries in the region, where
health care resources, including infrastructures, health
care professionals, and more complete service packages,
tend to be relatively concentrated in more urbanized
areas, and where long travel distances limit access to ser-
vices for rural populations [20, 21]. It forms a case study
which illustrates, again, that the recommendations of the
Maputo Declaration in 2008 are still valid, and need to be
transformed into action in Mozambique and other similar
low-income countries.
Conclusions
This study shows that laboratory services are considered
very important for access, health care quality and disease
control in rural populations in Tete province, Mozambique.
Therefore, the expansion of the laboratory network should
be an appropriately funded priority of the national health
system. A National Laboratory Policy in Mozambique
would be able to establish rules for the expansion of the la-
boratory network and calculate required costs to facilitate
the mobilization of funding. Parallel to the laboratory net-
work expansion, enhanced supply chain management is es-
sential to ensure the provision of uninterrupted services in
established laboratories, ensuring maximum utilization and
quality of the currently low installed capacity.
These recommendations require a serious investment
in the area, so key stakeholders have an important role
to play: national health authorities must set policies and
priorities, while government and development cooper-
ation partners should allocate the required resources.
Only then the laboratory services will be able to contrib-
ute fully to achieving Universal Health Coverage as a
core capacity of the national health system [1, 3, 4].
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